Drugs for Treatment of Bone Cancer

Aclarubicin

Aclarubicin or aclacinomycin A is used to treat acute non lymphocytic leukemia, a cancer of the blood and bone marrow.

Trade Names :
Klasinomycin
More ...

Arsenic Trioxide

In the treatment of acute promyelocytic leukemia, arsenic trioxide has been known to display strong anti-tumor effects with few toxic effects.

Trade Names :
Arsikem (10mg)
More ...

Burosumab-twza

Burosumab-twza or KRN23 is a monoclonal antibody prescribed to treat a rare hereditary disorder called X-linked hypophosphatemia (low levels of phosphate in the blood) in adult and pediatric patients who are one year and above.

Advertisement

Dactinomycin

Dactinomycin is a cytotoxic chemotherapy, prescribed for Wilm's tumor, Ewing’s sarcoma and testicular cancer.

Trade Names :
Cosmegen | Dacmozen | Dactino | Dactinoget
More ...

Denosumab

Denosumab is a human monoclonal antibody, prescribed for osteoporosis, treatment induced bone loss, bone metastases, rheumatoid arthritis, multiple myeloma and giant cell tumor of bone.

Doxorubicin

Doxorubicin is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.

Trade Names :
Doxolem | Tevadox | Doxorubicin | Adrosal |    Duxocin |    Duxocin | Adriamycin (50 mg) | Adrim | Adrim (2 mg) | Cardia
More ...

Advertisement

Elotuzumab

Elotuzumab is used to treat multiple myeloma, a type of cancer in the bone marrow in adult patients whose cancer has returned after successful treatment or in patients who showed treatment failure with one to three cancer treating medications

Idelalisib

Idelalisib is prescribed to treat patients with cancer of the blood or bone marrow such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma (FL) whose cancer has returned after treating with some anti-cancer medicines

Ivosidenib

Ivosidenib tablets for oral use are prescribed to treat acute myeloid leukemia (AML)

Advertisement

Ixazomib

Ixazomib is used to treat multiple myeloma along with drugs lenalidomide and dexamethasone in adult patients who have already been treated with one therapy of cancer-treating medications

Midostaurin

Midostaurin is a kinase inhibitor prescribed as a combination therapy with cytarabine and daunorubicin for treating adult patients with acute myeloid leukemia who are detected as FLT3 mutation-positive by an FDA approved test

Moxetumomab pasudotox-tdfk

Moxetumomab pasudotox-tdfk is prescribed to treat Hairy Cell Leukemia (HCL) in adult patients who had treatment failure with at least two treatments or whose cancer returned after chemotherapy

Vindesine

Vindesine is used to treat several cancers such as leukemia, lymphomas, and some solid tumors such as breast cancer and lung cancer either as a single agent or in combination with other cancer-treating drugs